MANHATTAN PSYCHIATRIC CENTER

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1848-01-01
Employees
-
Market Cap
-
Website

Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations

First Posted Date
2018-04-02
Last Posted Date
2018-04-04
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
27
Registration Number
NCT03485131
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, New York, New York, United States

Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2009-02-06
Last Posted Date
2020-10-14
Lead Sponsor
Manhattan Psychiatric Center
Registration Number
NCT00838227

Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia

First Posted Date
2008-04-22
Last Posted Date
2015-04-17
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
142
Registration Number
NCT00664274
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, Wards Island, New York, United States

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

First Posted Date
2008-04-21
Last Posted Date
2010-08-09
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
295
Registration Number
NCT00661869
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, New York, New York, United States

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

Phase 4
Completed
Conditions
Interventions
First Posted Date
2007-07-16
Last Posted Date
2015-04-15
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
20
Registration Number
NCT00501618
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, 125th Street, Out Patient Clinic, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, Inpatient Unit, New York, New York, United States

Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2007-02-05
Last Posted Date
2020-10-06
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
11
Registration Number
NCT00431223
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, New York, New York, United States

Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-11-02
Last Posted Date
2011-07-29
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
57
Registration Number
NCT00395031
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, New York, New York, United States

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-03-01
Last Posted Date
2015-04-17
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
60
Registration Number
NCT00297947
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Manhattan Psychiatric Center, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Nathan Kline Institute for Psychiatric Research, Orangeburg, New York, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath